Seamus Mulligan's Net Worth
$837 Million
Who is Seamus Mulligan?
Seamus Mulligan has an estimated net worth of $837 Million. This is based on reported shares across multiple companies, which include Jazz Pharmaceuticals plc, and Emergent BioSolutions Inc..
SEC CIK
Seamus Mulligan's CIK is 0001536639
Past Insider Trading and Trends
2020 was Seamus Mulligan's most active year for acquiring shares with 7 total transactions. Seamus Mulligan's most active month to acquire stocks was the month of July. 2014 was Seamus Mulligan's most active year for disposing of shares, totalling 38 transactions. Seamus Mulligan's most active month to dispose stocks was the month of February. 2018 saw Seamus Mulligan paying a total of $7,228,001.04 for 55,230 shares, this is the most they've acquired in one year. In 2012 Seamus Mulligan cashed out on 2,864,954 shares for a total of $99,120,000.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Jazz Pharmaceuticals plc (JAZZ) Snapshot price: $123.21
See Remarks
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +0.26% | 3.08K |
—
|
—
| 1.17M |
Aug 11
| |||
Form 4
| +0.39% | 4.5K |
$81.76 | $367,920.00 | 1.17M |
Jun 8
| |||
Form 4
| +0.39% | 4.5K |
$59.13 | $266,085.00 | 1.16M |
Mar 4
| |||
Form 4
| +0.22% | 2.56K |
—
|
—
| 1.16M |
Aug 5
| |||
Form 4
| +0.19% | 2.25K |
—
|
—
| 1.16M |
Jul 29
| |||
Form 4
| +0.23% | 2.71K |
—
|
—
| 1.16M |
Aug 6
| |||
Form 4
| +4.53% | 50K |
$111.08 | $5,553,804.93 | 1.15M |
May 26 - May 27
| |||
Form 4
| +0.17% | 1.92K |
—
|
—
| 1.1M |
Aug 8
| |||
Form 4
| +4.76% | 50K |
$144.56 | $7,228,001.03 | 1.1M |
Nov 15
| |||
Form 4
| +0.14% | 1.5K |
—
|
—
| 1.05M |
Aug 9
| |||
Form 4
| +0.13% | 1.36K |
—
|
—
| 1.05M |
Aug 10
| |||
Form 4
| -2.60% | -27.97K |
$128.32 | -$3,588,787.11 | 1.05M |
Scheduled
|
Aug 25
| ||
Form 4
| +0.13% | 1.36K |
—
|
—
| 1.08M |
Aug 11
| |||
Form 4
| -2.54% | -27.97K |
$150.29 | -$4,203,338.90 | 1.07M |
Scheduled
|
May 24
| ||
Form 4
| -2.47% | -27.97K |
$122.71 | -$3,431,904.17 | 1.1M |
Scheduled
|
Feb 23
| ||
Form 4
| -2.41% | -27.97K |
$145.86 | -$4,079,295.97 | 1.13M |
Scheduled
|
Nov 20 - Nov 23
| ||
Form 4
| +0.11% | 1.31K |
—
|
—
| 1.16M |
Aug 7
| |||
Form 4
| -4.14% | -50.00K |
$174.59 | -$8,729,522.46 | 1.16M |
Scheduled
|
Mar 25
| ||
Form 4
| -3.98% | -50.00K |
$185.00 | -$9,250,000.00 | 1.21M |
Scheduled
|
Mar 18
| ||
Form 4
| -3.82% | -50.00K |
$163.40 | -$8,169,891.64 | 1.26M |
Scheduled
|
Dec 23 - Dec 26
| ||
Form 4
| -3.68% | -50.00K |
$163.16 | -$8,157,755.53 | 1.31M |
Scheduled
|
Sep 24 - Sep 25
| ||
Form 4
| -3.55% | -50.00K |
$175.00 | -$8,750,000.00 | 1.36M |
Scheduled
|
Sep 11
| ||
Form 4
| +0.12% | 1.65K |
—
|
—
| 1.41M |
Aug 7
| |||
Form 4
| -3.44% | -50.00K |
$149.69 | -$7,484,734.70 | 1.41M |
Scheduled
|
Jun 24 - Jun 25
| ||
Form 4
| -27.42% | -550.00K |
$156.25 | -$85,937,500.00 | 1.46M |
Mar 4
| |||
Form 4
| +0.11% | 2.25K |
—
|
—
| 2.01M |
Aug 8
| |||
Form 4/A
| -17.43% | -422.75K |
$58.28 | -$24,769,000.00 | 2M |
Mar 5 - Mar 8
| |||
Form 4
| -17.43% | -422.75K |
$58.28 | -$24,769,000.00 | 2M |
Mar 5 - Mar 8
| |||
Form 4
| +0.72% | 17.5K |
—
|
—
| 2.44M |
Aug 9
| |||
Form 4
| -37.80% | -2.00M |
$49.56 | -$99,120,000.00 | 3.29M |
Mar 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Emergent BioSolutions Inc. (EBS) Snapshot price: $1.495
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +15.58% | 7.57K |
—
|
—
| 56.14K |
Mar 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||